NO960217L - Stabilisering av aerosoliserte proteiner - Google Patents

Stabilisering av aerosoliserte proteiner

Info

Publication number
NO960217L
NO960217L NO960217A NO960217A NO960217L NO 960217 L NO960217 L NO 960217L NO 960217 A NO960217 A NO 960217A NO 960217 A NO960217 A NO 960217A NO 960217 L NO960217 L NO 960217L
Authority
NO
Norway
Prior art keywords
stabilized
proteins
aerosolization
surfactant
stabilization
Prior art date
Application number
NO960217A
Other languages
English (en)
Norwegian (no)
Other versions
NO960217D0 (no
Inventor
Tsutomu Arakawa
Ralph W Niven
Steven J Prestrelski
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of NO960217D0 publication Critical patent/NO960217D0/no
Publication of NO960217L publication Critical patent/NO960217L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Colloid Chemistry (AREA)
NO960217A 1993-07-19 1996-01-18 Stabilisering av aerosoliserte proteiner NO960217L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9384093A 1993-07-19 1993-07-19
PCT/US1994/008136 WO1995003034A1 (en) 1993-07-19 1994-07-19 Stabilization of aerosolized proteins

Publications (2)

Publication Number Publication Date
NO960217D0 NO960217D0 (no) 1996-01-18
NO960217L true NO960217L (no) 1996-03-18

Family

ID=22241106

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960217A NO960217L (no) 1993-07-19 1996-01-18 Stabilisering av aerosoliserte proteiner

Country Status (8)

Country Link
EP (1) EP0710102A1 (de)
JP (1) JPH09501418A (de)
AU (1) AU691514B2 (de)
CA (1) CA2167538A1 (de)
FI (1) FI960253L (de)
NO (1) NO960217L (de)
NZ (1) NZ271181A (de)
WO (1) WO1995003034A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113271A1 (en) * 1997-01-29 2003-06-19 University Technology Corporation Formulations for pulmonary delivery
DE19733651A1 (de) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
EP1244432A2 (de) * 1999-12-30 2002-10-02 Chiron Corporation Verfahren zur pulmonaren verabreichung von interleukin-2
DK1129720T3 (da) 2000-02-29 2004-09-27 Pfizer Prod Inc Stabiliseret granulocyt-kolonistimulerende faktor
EP1471871B1 (de) 2001-02-02 2007-05-02 Ortho-McNeil Pharmaceutical, Inc. Behandlung von neurologischen funktionsstörungen mit fructopyranosesulfamaten und erythropoetin
US20030072717A1 (en) 2001-02-23 2003-04-17 Vapotronics, Inc. Inhalation device having an optimized air flow path
WO2002094342A2 (en) * 2001-05-21 2002-11-28 Vapotronics, Inc. Compositions for protein delivery via the pulmonary route
JP2004087560A (ja) 2002-08-23 2004-03-18 Sansha Electric Mfg Co Ltd 電源装置
TW200938222A (en) * 2007-12-13 2009-09-16 Glaxo Group Ltd Compositions for pulmonary delivery
EP2077132A1 (de) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Abgabevorrichtung, Aufbewahrungsvorrichtung und Verfahren zur Abgabe einer Formulierung
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
PE20130036A1 (es) 2009-11-25 2013-02-03 Boehringer Ingelheim Int Nebulizador
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
CN103717239B (zh) 2011-08-02 2017-08-01 希格马托制药工业公司 适合于吸入的氧化抗生物素蛋白的药物组合物
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
EP3030298B1 (de) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Vernebler
EP2835146B1 (de) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Zerstäuber
AP2016009486A0 (en) 2014-05-07 2016-10-31 Boehringer Ingelheim Int Nebulizer, indicator device and container
HUE055604T2 (hu) 2014-05-07 2021-12-28 Boehringer Ingelheim Int Porlasztó
WO2015169732A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Container, nebulizer and use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897256A (en) * 1986-11-25 1990-01-30 Abbott Laboratories LHRH analog formulations
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
RU2054180C1 (ru) * 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций

Also Published As

Publication number Publication date
NZ271181A (en) 1998-06-26
JPH09501418A (ja) 1997-02-10
NO960217D0 (no) 1996-01-18
AU7473294A (en) 1995-02-20
FI960253A7 (fi) 1996-03-18
FI960253A0 (fi) 1996-01-18
EP0710102A1 (de) 1996-05-08
AU691514B2 (en) 1998-05-21
CA2167538A1 (en) 1995-02-02
FI960253L (fi) 1996-03-18
WO1995003034A1 (en) 1995-02-02

Similar Documents

Publication Publication Date Title
NO960217L (no) Stabilisering av aerosoliserte proteiner
EP0677048A1 (de) Cyclische sulfone als inhibitoren retroviralen proteasen.
NO180538C (no) N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer, farmasöytiske blandinger som inneholder dem og mellomprodukter ved fremstilling av derivatene
CA2232604A1 (fr) Procede de conservation de virus recombinants infectieux, suspension aqueuse virale et utilisation comme medicament
AU4624097A (en) Thio acid derived monocyclic (n)-heterocyclics as anticoagulants
NZ303861A (en) Amino acid hydroxyethylamine sulphonamide derivatives as protease inhibitors
ATE254478T1 (de) Stabile zusammensetzungen enthaltend ein retinoid und ein antioxidierendes system auf enzymbasis
DK0929547T3 (da) Benzamidinderivater substitueret af cykliske aminosyrederivater eller cykliske hydroxysyrederivater og deres anvendelse som antikoagulantia
BR9607543A (pt) Inibidores de protease retroviral sulfonamida hidroxietilamino de bis-amino ácido
AU3506184A (en) Foamable biocide composition
CA2215066A1 (en) Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
BR9814104A (pt) Compostos benzeno substituìdos, processo parasua preparação e composições herbicidas edesfolhantes contendo os mesmos
AU5417896A (en) Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
TR21863A (tr) Karisim dispersiyonlari seklinde bitki koruma maddeleri
AU5327386A (en) Peptide derivatives, analogous to pepstatin, which inhibit renin and acid proteases.
DK1096865T3 (da) Antimikrobiel sammensætning
AU4765396A (en) Method of preparing retroviral protease inhibitor intermediates
AU4459300A (en) Anti-corrosion solutions for air dehumidification systems
AU679581B2 (en) Method of stabilizing protein C or activated protein C and stabilized composition
BR0107556A (pt) Processo de fumigação de um sistema fechado
EP1087011A3 (de) Verfahren zur Verhinderung der Zersetzung des Proteins C
AU5589294A (en) Succinoylamino hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
NO953029L (no) Fremgangsmåte for kontroll av makroinvertebrater
ES2135843T3 (es) Isomerizacion de equilina.
WO2001096398A3 (en) Uncoupling proteins as targets for the treatment of heart failure

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application